Oculis Holding AG (OCS) EV to EBITDA (2023 - 2026)
Oculis Holding AG's EV to EBITDA was 190.55 in Q2 2026, down 53.6% from 410.65 a year earlier and down 63.4% from the prior quarter.
Powered by 
Analysis
Oculis Holding AG (OCS) EV to EBITDA (2023 - 2026) Analysis & Trends
On a trailing twelve-month basis, Oculis Holding AG's EV to EBITDA was -129.36 through Jun 30, 2026; for FY2025, it was 355.78, down 23.2% from FY2024.
- In earlier years, EV to EBITDA was 463.04 in FY2024 (+72.7%), 268.10 in FY2023 (+158.8%), 103.61 in FY2022 (+24.5%) and 83.22 in FY2021.
- The Q2 2026 figure marks the lowest quarterly EV to EBITDA since Q3 2024.
- Compared with a year earlier, EV to EBITDA was higher in six of the last eight quarters, with growth averaging 48.0%.
- The best year-over-year quarter for EV to EBITDA over five years was Q2 2025 (growth of 140.7%); the worst was Q2 2026 (a decline of 53.6%).
- Per Business Quant data, OCS's EV to EBITDA in the three quarters before Q2 2026 was 521.26 (Q1 2026), 367.92 (Q4 2025) and 342.96 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,132.34 Bn | 1,100.93 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 615.91 Bn | 534.44 Bn | 17.26 Bn |
| 3 | AbbVie | 505.47 Bn | 478.59 Bn | 12.70 Bn |
| 4 | Merck | 368.25 Bn | 322.63 Bn | 12.21 Bn |
| 5 | Novartis Ag | 298.18 Bn | 262.17 Bn | 11.24 Bn |
| 6 | Astrazeneca | 261.66 Bn | 235.34 Bn | 12.86 Bn |
| 7 | Amgen | 236.22 Bn | 191.62 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 190.68 Bn | 164.87 Bn | 6.22 Bn |
| 9 | Pfizer | 170.14 Bn | 116.79 Bn | 10.94 Bn |
| 10 | Oculis Holding AG | 397.05 Mn | -614.43 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 193.24 |
| Mar 31, 2026 | 524.07 |
| Dec 31, 2025 | 366.72 |
| Sep 30, 2025 | 342.56 |
| Jun 30, 2025 | 405.65 |
| Mar 31, 2025 | 414.77 |
| Dec 31, 2024 | 465.82 |
| Sep 30, 2024 | 173.51 |
| Jun 30, 2024 | 169.99 |
| Mar 31, 2024 | 200.37 |
| Dec 31, 2023 | 174.31 |
| Sep 30, 2023 | 34.27 |
| Jun 30, 2023 | 43.74 |
API Access
Oculis Holding AG EV to EBITDA API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ev-to-ebitda&ticker=OCS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ev-to-ebitda", "ticker": "OCS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ev-to-ebitda&ticker=OCS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();